IVIG

What can we help you find?
[[thumbnail_alt_text]]
Carefully implemented order sets may encourage evidence-based or institution-specific care though the influence of provider behavior.
[[thumbnail_alt_text]]
Five-day adjuvant IVIG therapy found to significantly reduce viral load in an immunocompromised patient with severe varicella.
[[thumbnail_alt_text]]
The case study included a 45-year-old man diagnosed with stage 3 multiple myeloma who was treated with bortezomib and dexamethasone.
[[thumbnail_alt_text]]
The study authors wanted to determine the prevalence and clinical significances of red blood cell-bound immunoglobulin G as detected by flow cytometry in polytransfused patients with thalassemia.
[[thumbnail_alt_text]]
IVIG found to have a good safety profile in pediatric patients, with low risk of severe adverse drug reactions.
[[thumbnail_alt_text]]
Study is the first to identify the presence of anti-citrullinated protein autoantibodies in human tear fluid as well as discover the new eye drop treatment.
[[thumbnail_alt_text]]
Study seeks to determine the prevalence and clinical significance of red blood cell-bound immunoglobulin G as detected by flow cytometry in polytransfused patients with thalassemia.
[[thumbnail_alt_text]]
Metabolic activity in the immune cells of patients with primary immunodeficiency was used as a biomarker due to cellular metabolism, which serves as a key regulator in immune cells.
[[thumbnail_alt_text]]
Debilitating and degenerative, chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disease affecting 1.6 per 100,000 Americans annually.
[[thumbnail_alt_text]]
Trial finds that the addition of anti-HIV immune globulin to standard of care patients with influenza B had a significant virological benefit.
[[thumbnail_alt_text]]
In a Pharmacy Times® Continuing Education Supplement, Leslie J. Vaughan, BS, RPH, examined cost and health care utilization in patients using immunoglobulin agents.
[[thumbnail_alt_text]]
Subcutaneous immunoglobin has increased treatment options for patients with several conditions, such as primary immunodeficiency diseases and chronic inflammatory demyelinating polyneuropathy.